Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

MLA

Thamilarasan, Madhan, et al. “Mn Porphyrins as a Novel Treatment Targeting Sickle Cell NOXs to Reverse and Prevent Acute Vaso-Occlusion in Vivo.” Blood Advances, vol. 4, no. 11, June 2020, pp. 2372–86. EBSCOhost, https://doi.org/10.1182/bloodadvances.2020001642.

APA

Thamilarasan, M., Estupinan, R., Batinic-Haberle, I., & Zennadi, R. (2020). Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo. Blood Advances, 4(11), 2372–2386. https://doi.org/10.1182/bloodadvances.2020001642

Chicago

Thamilarasan, Madhan, Rodolfo Estupinan, Ines Batinic-Haberle, and Rahima Zennadi. 2020. “Mn Porphyrins as a Novel Treatment Targeting Sickle Cell NOXs to Reverse and Prevent Acute Vaso-Occlusion in Vivo.” Blood Advances 4 (11): 2372–86. doi:10.1182/bloodadvances.2020001642.